摘要
一氧化氮(NO)是一种信号基、高扩散性的多效性调节大量不同的分子生物学通路,包括神经递质、血管扩张和抗感染的宏观噬菌体介导的反应。它是由氨基酸L-精氨酸和氧通过三种亚型一氧化氮合酶(NOS)的酶的作用产生的,并在组织中得到不同的表达和调节。 越来越多的证据表明,在不同的病理条件下包括癌症都有NO的广泛作用。这种分子双重作用作为一个亲和抗致瘤性的介质已被报道。此外,NO通过作为一个效应分子调节先天免疫反应和作为适应性免疫成分的调节器而发挥着许多的免疫效果。 本文回顾了多种信号分子在肿瘤生物学领域的最新进展,对免疫调节、NO效应物的活性和氮分子(RNS)进行了简洁的描述。特别是,我们总结了最近NO在癌症发病机制中的复杂功能的分子机制。我们还将针对新兴的由NO调节的免疫介导机制,为控制癌症过程并能被NO 影响的复杂的细胞相互作用提供全面的观点。
关键词: 一氧化氮,RNS,肿瘤,免疫逃逸,TAM,MDSCs,一氧化氮供体,微环境,化学免疫治疗。
Current Medicinal Chemistry
Title:Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer
Volume: 23 Issue: 24
Author(s): Cinzia Fionda, Maria Pia Abruzzese, Angela Santoni, Marco Cippitelli
Affiliation:
关键词: 一氧化氮,RNS,肿瘤,免疫逃逸,TAM,MDSCs,一氧化氮供体,微环境,化学免疫治疗。
摘要: Nitric Oxide (NO) is a signaling radical, highly diffusible pleiotropic regulator of a large set of different molecular and biological pathways, including, neurotransmission, vasodilatation and macrophagemediated responses against infections. It is produced from the amino acid L-Arginine and oxygen by the enzymatic action of three isoforms of the Nitric Oxide Synthase (NOS), differently expressed and regulated in tissues.
Increasing evidence highlights the wide spectrum of action of NO in different pathologic conditions, including cancer. In this regard, a dual role for this molecule as a pro- and anti-tumorigenic mediator has been described, in a context and concentration-dependent manner. Moreover, NO exerts numerous immunologic effects, by operating as an effector molecule in innate immune responses as well as a regulator of adaptive immune components.
Here, we will review recent advances in the field of biology of this pleiotropic signaling molecule in cancer, also providing a concise description of the immunoregulatory and effector activities of NO and Reactive Nitrogen Species (RNS). In particular, we will summarize recent knowledge of the molecular mechanisms underlying the complex functions of NO in cancer pathogenesis. We will also address emerging immune-mediated mechanisms regulated by NO to provide a comprehensive view of the complex cellular interactions which control cancer progression and that can be influenced by NO at multiple levels. In the light of different immunologic effects of this molecule, the potential therapeutic implications of novel drugs targeting NO to treat cancer and to improve anti-tumor immune responses will be discussed.
Export Options
About this article
Cite this article as:
Cinzia Fionda, Maria Pia Abruzzese, Angela Santoni, Marco Cippitelli , Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160727105101
DOI https://dx.doi.org/10.2174/0929867323666160727105101 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ezogabine: Development and Role in the Management of Epileptic Seizures
Mini-Reviews in Medicinal Chemistry Adverse Drug Reactions Amongst Adult Patients Admitted in Lagos State University Teaching Hospital Lagos, Nigeria
Current Drug Safety Food Allergy
Current Pharmaceutical Design Activated Carbon/MoO<sub>3</sub>: Efficient Catalyst for Green Synthesis of Chromeno[<i>d</i>]pyrimidinediones and Xanthenones
Combinatorial Chemistry & High Throughput Screening Is Combination Therapy of Atosiban and Nifedipine More Effective in Preterm Labor than Each Drug Alone? A Prospective Study
Current Women`s Health Reviews Classical Neurotransmitters and Neuropeptides Involved in Schizophrenia: How to Choose the Appropriate Antipsychotic Drug?
Current Drug Therapy Roles of Renal Proximal Tubule Transport in the Pathogenesis of Hypertension
Current Hypertension Reviews Polyglandular Autoimmune Syndromes
Current Immunology Reviews (Discontinued) Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Current Neuropharmacology Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders
Current Drug Metabolism Subject Index To Volume 4
Current Vascular Pharmacology Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Nociceptin/Orphanin FQ Peptide Receptors: Pharmacology and Clinical Implications
Current Drug Targets Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery Inhibitory Effect of PD-1/PD-L1 and Blockade Immunotherapy in Leukemia
Combinatorial Chemistry & High Throughput Screening Diabetes and Nutritional Screening in Post-Bariatric Patients
Current Diabetes Reviews Glucocorticoid Measurements in Health and Disease - Metabolic Implications and the Potential of 24-h Urine Analyses
Mini-Reviews in Medicinal Chemistry Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
Current Pharmaceutical Design Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Current Drug Targets A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer's Disease
Current Alzheimer Research